United States Pharmaceuticals

GL Brands Inc (GRLB)

Track

Ticker: GRLB Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
RSGroberg Consulting LLC former Director
Transaction date
Purchase
Price
292.05
Quantity 27,505 -6.7%
Value US$3,793,946
Pelosi Paul Francis Jr Non-Executive Director
Transaction date
Purchase
Price
100.00
Quantity 9,431 +43.1%
Value US$1,730,499
Sloan Christopher Michael former COO
Transaction date
Sale
Price
389.00
Quantity 8,333 +32.1%
Value US$1,687,532
Sloan Christopher Michael former COO
Transaction date
Sale
Price
0.26
Quantity 10,000 -1.2%
Value US$2,620
Pelosi Paul Francis Jr Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 1,050,000 +57.8%
Value US$21,000
Sloan Christopher Michael COO Officer
Transaction date
Sale
Price
0.14
Quantity 20,000 -2.4%
Value US$2,700
Sloan Christopher Michael COO Officer
Transaction date
Sale
Price
0.10
Quantity 25,000 -2.9%
Value US$2,450
Sloan Christopher Michael COO Officer
Transaction date
Sale
Price
0.07
Quantity 20,000 -2.3%
Value US$1,480
Halford Joshua Martin CTO
Transaction date
Sale
Price
0.04
Quantity 65,271 -12.3%
Value US$2,813
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 20,000 -2.2%
Value US$940
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 20,000 -2.2%
Value US$960
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 30,000 -3.1%
Value US$1,392
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 20,000 -2.1%
Value US$1,000
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 40,000 -3.9%
Value US$1,920
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.07
Quantity 24,996 -2.4%
Value US$1,625
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.06
Quantity 15,000 -1.4%
Value US$882
Pelosi Paul Francis Jr Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 967,000 +113.8%
Value US$14,505
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.07
Quantity 11,085 -1.0%
Value US$787
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.05
Quantity 11,085 -1.0%
Value US$509
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.04
Quantity 11,085 -1.0%
Value US$466
Sloan Christopher Michael COO
Transaction date
Sale
Price
0.03
Quantity 12,343 -1.1%
Value US$358
Halford Joshua Martin Chief Technology Officer
Transaction date
Purchase
Price
22,000.00
Quantity 550,000 +inf%
Value US$12,100,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-08-15 2019-08-14 B Purchase RSGroberg Consulting LLC

former Director
27,505 -6.7%
292.05
US$3,793,946 		27,505 -6.7% 292.05 US$3,793,946
2018-08-08 2018-07-27 B Purchase Pelosi Paul Francis Jr Non-Executive Director
9,431 +43.1%
100.00
US$1,730,499 		9,431 +43.1% 100.00 US$1,730,499
2018-01-25 2018-01-24 S Sale Sloan Christopher Michael

former COO
8,333 +32.1%
389.00
US$1,687,532 		8,333 +32.1% 389.00 US$1,687,532
2018-01-25 2018-01-23 S Sale Sloan Christopher Michael

former COO
10,000 -1.2%
0.26
US$2,620 		10,000 -1.2% 0.26 US$2,620
2018-08-08 2018-01-18 B Purchase Pelosi Paul Francis Jr Non-Executive Director
1,050,000 +57.8%
0.02
US$21,000 		1,050,000 +57.8% 0.02 US$21,000
2018-01-12 2018-01-11 S Sale Sloan Christopher Michael

COO

Officer
20,000 -2.4%
0.14
US$2,700 		20,000 -2.4% 0.14 US$2,700
2018-01-12 2018-01-09 S Sale Sloan Christopher Michael

COO

Officer
25,000 -2.9%
0.10
US$2,450 		25,000 -2.9% 0.10 US$2,450
2018-01-09 2018-01-05 S Sale Sloan Christopher Michael

COO

Officer
20,000 -2.3%
0.07
US$1,480 		20,000 -2.3% 0.07 US$1,480
2017-12-28 2017-12-26 S Sale Halford Joshua Martin

CTO
65,271 -12.3%
0.04
US$2,813 		65,271 -12.3% 0.04 US$2,813
2017-12-20 2017-12-19 S Sale Sloan Christopher Michael

COO
20,000 -2.2%
0.05
US$940 		20,000 -2.2% 0.05 US$940
2017-12-18 2017-12-15 S Sale Sloan Christopher Michael

COO
20,000 -2.2%
0.05
US$960 		20,000 -2.2% 0.05 US$960
2017-12-12 2017-12-12 S Sale Sloan Christopher Michael

COO
30,000 -3.1%
0.05
US$1,392 		30,000 -3.1% 0.05 US$1,392
2017-12-12 2017-12-08 S Sale Sloan Christopher Michael

COO
20,000 -2.1%
0.05
US$1,000 		20,000 -2.1% 0.05 US$1,000
2017-12-04 2017-12-01 S Sale Sloan Christopher Michael

COO
40,000 -3.9%
0.05
US$1,920 		40,000 -3.9% 0.05 US$1,920
2017-11-24 2017-11-21 S Sale Sloan Christopher Michael

COO
24,996 -2.4%
0.07
US$1,625 		24,996 -2.4% 0.07 US$1,625
2017-11-15 2017-11-13 S Sale Sloan Christopher Michael

COO
15,000 -1.4%
0.06
US$882 		15,000 -1.4% 0.06 US$882
2018-08-08 2017-11-10 B Purchase Pelosi Paul Francis Jr Non-Executive Director
967,000 +113.8%
0.02
US$14,505 		967,000 +113.8% 0.02 US$14,505
2017-11-09 2017-11-09 S Sale Sloan Christopher Michael

COO
11,085 -1.0%
0.07
US$787 		11,085 -1.0% 0.07 US$787
2017-11-08 2017-11-08 S Sale Sloan Christopher Michael

COO
11,085 -1.0%
0.05
US$509 		11,085 -1.0% 0.05 US$509
2017-11-07 2017-11-07 S Sale Sloan Christopher Michael

COO
11,085 -1.0%
0.04
US$466 		11,085 -1.0% 0.04 US$466
2017-11-07 2017-11-02 S Sale Sloan Christopher Michael

COO
12,343 -1.1%
0.03
US$358 		12,343 -1.1% 0.03 US$358
2017-09-26 2017-08-29 B Purchase Halford Joshua Martin

Chief Technology Officer
550,000 +inf%
22,000.00
US$12,100,000,000 		550,000 +inf% 22,000.00 US$12,100,000,000
Explore more

More insider trading research around GL Brands Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America